The optimal effect site concentration of remifentanil for minimizing injection pain during induction with propofol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000147

Enrollment

Registered

2011-07-20

Start date

2010-06-25

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Using Dixon’s up and down method, the degree of pain described by the patient was used to adjust the target concentration of remifentanil for the next patient.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female patients undergoign general anesthesia for elective surgery using TCI system.

Exclusion criteria

Exclusion criteria: We excluded all patients with difficult venous access, those with known allergy to egg lecithin or soybean oil, severe neurological deficits or psychiatric disorders, and habituation to analgesics, sedatives or anti-anxiety drugs.

Design outcomes

Primary

Measure	Time frame
The optimal effect site concentration of remifentanil in 50% and 95% of adult female population for minimizing injection pain of propofol	—

Secondary

Measure	Time frame
hemodynamic variables	—

Countries

Korea, Republic of

Contacts

Public ContactDuk-Hee Chun

Bundang CHA General Hospital

leah1013@chamc.co.kr+82-31-780-5643

Outcome results